XML 46 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Share-based Payments
12 Months Ended
Dec. 31, 2018
Share-Based Payment Arrangements [Abstract]  
Share-based Payments
SHARE-BASED PAYMENTS

Stock option plan

The Company operates a stock option plan (the "Plan") to provide equity-settled share-based remuneration to directors, officers and employees. The number of common shares that may be issued pursuant to the exercise of options awarded under the Plan and all other Security Based Compensation Arrangements of the Company is 10% of the common shares outstanding from time to time. All incentive stock options granted under the Plan have a per-share exercise price equal to the weighted average trading price of the common shares for the five trading days prior to the date of grant. Each tranche of an award with different vesting dates is considered a separate grant for the calculation of fair value and the resulting fair value is amortized over the vesting period of the respective tranche.

The following tables summarize information about the stock options outstanding and exercisable at the dates indicated:
 
 
2018
 
 
2017
 
 
 
 
 
Weighted-

 
 
 
Weighted-

 
 
Number

 
Average

 
Number

 
Average

 
 
of

 
Exercise

 
of

 
Exercise

(000s except per share amounts)
 
Options

 
Price (C$)

 
Options

 
Price (C$)

Options outstanding, beginning of year
 
4,959

 
5.10

 
6,046

 
6.87

Granted
 
1,071

 
2.62

 
1,043

 
2.16

Cancelled / Forfeited
 

 

 
(1,281
)
 
6.75

Expired
 
(1,154
)
 
9.13

 
(849
)
 
11.43

Options outstanding, end of year
 
4,876

 
3.60

 
4,959

 
5.10

Options exercisable, end of year
 
2,766

 
4.52

 
2,925

 
6.87



 
 
Options Outstanding
 
Options Exercisable
 
 
 
 
Weighted-

 
 
 
 
 
Weighted-

 
 
 
 
Number

 
Average

 
Weighted-

 
Number

 
Average

 
Weighted-

Exercise
 
Outstanding at

 
Remaining

 
Average

 
Exercisable at

 
Remaining

 
Average

Prices
 
December 31, 2018

 
Contractual

 
Exercise Price

 
December 31, 2018

 
Contractual

 
Exercise

(C$)
 
(000s)

 
Life (Years)

 
(C$)

 
(000s)

 
Life (Years)

 
Price (C$)

2.16 - 2.17
 
953

 
3.4

 
2.16

 
318

 
3.4

 
2.16

2.18 - 2.41
 
1,212

 
2.2

 
2.19

 
808

 
2.2

 
2.19

2.42 - 3.81
 
1,071

 
4.4

 
2.62

 

 

 

3.82 - 6.13
 
820

 
1.4

 
4.99

 
820

 
1.4

 
4.99

6.14 - 7.26
 
820

 
0.4

 
7.26

 
820

 
0.4

 
7.26

 
 
4,876

 
2.5

 
3.60

 
2,766

 
1.6

 
4.52


Compensation expense of $0.9 million was recorded in general and administrative expenses in the Consolidated Statements of Earnings (Loss) and Comprehensive Income (Loss) and Changes in Shareholders’ Equity during year ended December 31, 2018 (2017 - $0.6 million) in respect of stock options. The fair value of all common stock options granted is estimated on the date of grant using the lattice-based trinomial option pricing model.
The weighted average fair value of options granted during the period and the assumptions used in their determination are as noted below:
 
 
2018

 
2017

Weighted average fair market value per option (C$)
 
0.88

 
0.70

Risk free interest rate (%)
 
2.14
%
 
0.74
%
Expected volatility (based on actual historical volatility) (%)
 
49.45
%
 
48.67
%
Dividend rate
 
%
 
%
Expected forfeiture rate (non-executive employees) (%)
 
%
 
%
Suboptimal exercise factor
 
1.25

 
1.25



All options granted vest annually over a three-year period and expire five years after the grant date. During the year ended December 31, 2018, no employee stock options were exercised (2017nil). As at December 31, 2018 and December 31, 2017, the entire balance in contributed surplus was related to previously recognized share-based compensation expense on equity-settled stock options.

Restricted share unit, performance share unit and deferred share unit plans

In May 2014, the Company implemented a restricted share unit ("RSU") plan, a performance share unit ("PSU") plan and a deferred share unit ("DSU") plan.

RSUs may be issued to directors, officers and employees of the Company, and each RSU entitles the holder to a cash payment equal to the fair market value of a TransGlobe common share on the vesting date of the RSU. All RSUs granted vest annually over a three-year period, and all must be settled within 30 days of their respective vesting dates.

PSUs are similar to RSUs, except that the number of PSUs that ultimately vest is dependent on achieving certain performance targets and objectives as set by the Board of Directors. Depending on performance, vested PSUs granted prior to 2017 can range between 50% and 150% of the original PSU grant, and 0% to 200% for PSU's granted subsequent to 2017. All PSUs granted vest on the third anniversary of their grant date, and all must be settled within 60 days of their vesting dates.

DSUs are similar to RSUs, except that they become fully vested on the date of grant and are only issued to directors of the Company. Distributions under the DSU plan do not occur until the retirement of the DSU holder from the Company's Board of Directors.

The number of RSUs, PSUs and DSUs outstanding as at December 31, 2018:
(000s)
RSUs

 
PSUs

 
DSUs

Units outstanding, December 31, 2016
546

 
1,366

 
437

Granted
807

 
573

 
214

Exercised
(245
)
 
(248
)
 
(56
)
Forfeited
(138
)
 
(315
)
 

Units outstanding, December 31, 2017
970

 
1,376

 
595

Granted
410

 
678

 
225

Exercised
(361
)
 
(316
)
 

Forfeited
(163
)
 
(71
)
 

Reinvested
8

 
16

 
8

Units outstanding, December 31, 2018
864

 
1,683

 
828



Compensation expense of $2.7 million was recorded in general and administrative expenses in the Consolidated Statement of Earnings (Loss) and Comprehensive Income (Loss) during the year ended December 31, 2018 in respect of share units granted under the three plans described above (2017 - $0.8 million).